Paracelsus Medical University Clinical Study on Stereotaxis Technology Benefits Recognized at European Cardiac Arrhythmia Society Congress
“We utilize the Niobe system daily and trust it implicitly to improve the safety and efficacy of ablation procedures for atrial fibrillation, ventricular tachycardia and other complex cases,” said
The study analyzed data on 169 patients with symptomatic, persistent AF undergoing catheter ablation with the Niobe system, documenting fluoroscopy time for system calibration, transseptal access/catheter positioning and mapping/ablation. Total fluoroscopy time was 5.1±3.8 minutes, compared to an average of 14 to >60 minutes reported for traditional manual ablation procedures, and the effective radiation dose was 0.61±0.9 millisieverts (mSv) compared to the typical mean effective dose of 16.6 mSv reported for manual procedures, representing a 96% reduction.
The Nuremberg hospital, one of the largest in
The core components of Stereotaxis’ systems have received regulatory clearance in
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe”, "estimate”, "project”, "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its continued listing on the
Martin C. StammerChief Financial Officer 314-678-6155 Investor Contact: Todd Kehrli/ Jim Byers MKR Group, Inc. 323-468-2300 email@example.com